Prognostic value of the androgen receptor in addition to the established hormone receptors and HER2 status for predicting survival in women with early breast cancer

This is a protocol for a Cochrane Review (prognosis). The objectives are as follows:

This is a protocol.

Published:

16 November 2020

Authors:

Lokuhetty MDS, Wijesinghe HD, Damen JAAG, Lee T, White VA, Cree IA, Indave BIciar

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Lokuhetty MDS, Wijesinghe HD, Damen JAAG, Lee T, White VA, Cree IA, Indave BIciar. Prognostic value of the androgen receptor in addition to the established hormone receptors and HER2 status for predicting survival in women with early breast cancer (Protocol). Cochrane Database of Systematic Reviews 2020, Issue 11. Art. No.: CD013784. DOI: 10.1002/14651858.CD013784.